United States (US)

Galectin 1 recombinant protein

Cat No. GTX65158

Application ELISA, Functional Assay, Apuri, Blocking
Reactivity Human
Species Human

Application Note

Protein's bioactivity determined by its ability to chemoattract human blood monocytes. Chemotactic activity was observed at a concentration of 2.5 ug/ml with a peak response obtained at 250 ug/ml.

Calculated MW

14.5 kDa. ( Note )


Lyophilized powder


20 mM Tris, pH 7.5.


Reconstitute in water to a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers and stored at 4ºC for 1 week or –20ºfor future use.

Antigen Species


Expression System

E. coli


Purity was assessed by SDS-PAGE (≥98%) and by HPLC.


For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.


Galectin1, beta-galactoside- binding lectin L-14-I, SLac lectin1, Lectin galactosidebinding soluble1, betagalactoside binding lectin L14I, Lectin galactosidebinding soluble 1, Putative MAPK-activating protein PM12, LGALS1, L, S-Lac lectin 1, Galaptin, DKFZp686E23103, Putative MAPKactivating protein PM12, S Lac lectin 1, SLac lectin 1


Galectin-1 belongs to growing family of evolutionary conserved animal lectins. Galectins consists of beta-galactoside binding lectins that contain homologous carbohydrate recognition domains (CRDs). Galectin-1 has the ability to induce apoptosis of activated T-cells and T-leukaemia cell lines. Other activities include cell differentiation and inhibition activity of CD45 protein phosphatase activity. Galectin also binds beta-galactoside as well as CD45, CD3 and CD4. Recombinant Human Galectin is a 14.5 kDa protein consisting of 134 amino acid residues.

Research Area

Package List Price ($)
$ 249